{"version":"1.0","type":"rich","provider_name":"Everlit","provider_url":"https://everlit.audio/","title":"The Real Story Behind Globus’s Nevro Deal","description":"Nevro's financial struggles led to a $250 million acquisition by Globus, emphasizing the importance of service in spinal cord stimulation therapy.","author_name":"Orthopedics This Week","thumbnail_url":"https://cdn.everlit.audio/covers/artl_wQ0gGSAxr2P/eb18bb7b-6f72-4187-80e0-c014cae1ce2e/small.jpg","width":480,"height":136,"html":"\u003ciframe title=\"The Real Story Behind Globus’s Nevro Deal\" src=\"https://everlit.audio/embeds/artl_wQ0gGSAxr2P\" width=\"100%\" height=\"136px\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen\u003e\u003c/iframe\u003e"}